Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases
FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1
Fortis Healthcare Acquires Stake in Agilus Diagnostics
FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer
The Role of Big Data in Precision Medicine
Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes
OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients
Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease
FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC
Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC
Cartherics Receives $300K G-Rex Grant to Advance Cancer Cell Therapy Manufacturing
Roche Revolutionizes Mass Spectrometry Diagnostics with Launch of cobas® Mass Spec Solution
Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Sequencing Service Offerings
NeuroKaire Secures $10M to Transform Precision Medicine in Psychiatry and Neurology
Redcliffe Labs Announces Leadership Transition to Drive Healthcare Accessibility
